Reducing overdose deaths among persons with opioid use disorder in connecticut

被引:2
作者
Scheidell, Joy D. [1 ]
Townsend, Tarlise N. [2 ,3 ]
Zhou, Qinlian [2 ]
Manandhar-Sasaki, Prima [2 ]
Rodriguez-Santana, Ramon [4 ]
Jenkins, Mark [6 ]
Buchelli, Marianne [4 ,5 ]
Charles, Dyanna L. [2 ]
Frechette, Jillian M. [2 ]
Su, Jasmine I-Shin [2 ]
Braithwaite, R. Scott [2 ]
机构
[1] Univ Cent Florida, Dept Hlth Sci, POB 160000, Orlando, FL 32816 USA
[2] NYU, Grossman Sch Med, Dept Populat Hlth, 227 E 30th St, New York, NY 10016 USA
[3] NYU, Ctr Opioid Epidemiol & Policy, Grossman Sch Med, New York, NY USA
[4] Connecticut Dept Publ Hlth, HIV Prevent Program, 410 Capitol Ave, MS 11APV, Hartford, CT 06134 USA
[5] Connecticut Dept Publ Hlth, TB HIV STD & Viral Hepatitis Sect, 410 Capitol Ave, MS 11APV, Hartford, CT 06134 USA
[6] Connecticut Harm Reduct Alliance, 28 Grand St, Hartford, CT 06106 USA
关键词
Opioid use disorder; Opiate overdose; Harm reduction; Opiate medication-assisted treatment; Cost-effectiveness analysis; Modeling; NALOXONE DISTRIBUTION; COST-EFFECTIVENESS; UNITED-STATES; HEROIN USERS; RISK-FACTORS; DRUG-USERS; MORTALITY; PRISON; RELEASE; HEALTH;
D O I
10.1186/s12954-024-01026-6
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background People in Connecticut are now more likely to die of a drug-related overdose than a traffic accident. While Connecticut has had some success in slowing the rise in overdose death rates, substantial additional progress is necessary.Methods We developed, verified, and calibrated a mechanistic simulation of alternative overdose prevention policy options, including scaling up naloxone (NLX) distribution in the community and medications for opioid use disorder (OUD) among people who are incarcerated (MOUD-INC) and in the community (MOUD-COM) in a simulated cohort of people with OUD in Connecticut. We estimated how maximally scaling up each option individually and in combinations would impact 5-year overdose deaths, life-years, and quality-adjusted life-years. All costs were assessed in 2021 USD, employing a health sector perspective in base-case analyses and a societal perspective in sensitivity analyses, using a 3% discount rate and 5-year and lifetime time horizons.Results Maximally scaling NLX alone reduces overdose deaths 20% in the next 5 years at a favorable incremental cost-effectiveness ratio (ICER); if injectable rather than intranasal NLX was distributed, 240 additional overdose deaths could be prevented. Maximally scaling MOUD-COM and MOUD-INC alone reduce overdose deaths by 14% and 6% respectively at favorable ICERS. Considering all permutations of scaling up policies, scaling NLX and MOUD-COM together is the cost-effective choice, reducing overdose deaths 32% at ICER $19,000/QALY. In sensitivity analyses using a societal perspective, all policy options were cost saving and overdose deaths reduced 33% over 5 years while saving society $338,000 per capita over the simulated cohort lifetime.Conclusions Maximally scaling access to naloxone and MOUD in the community can reduce 5-year overdose deaths by 32% among people with OUD in Connecticut under realistic budget scenarios. If societal cost savings due to increased productivity and reduced crime costs are considered, one-third of overdose deaths can be reduced by maximally scaling all three policy options, while saving money.
引用
收藏
页数:15
相关论文
共 71 条
  • [1] Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose
    Abouk, Rahi
    Pacula, Rosalie Liccardo
    Powell, David
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (06) : 805 - 811
  • [2] Abuse NIoD, 2020, Substance Abuse in Older Adults DrugFacts
  • [3] [Anonymous], 2020, SAMHSA National Survey on Drug Use and Health
  • [4] [Anonymous], 2022, U.S. Overdose Deaths In 2021 Increased Half as Much as in 2020 - But Are Still Up 15%
  • [5] [Anonymous], 2022, Drug overdose mortality by state
  • [6] [Anonymous], 2019, Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings (Evidence-based Resource Guide Series)
  • [7] Modeling Mitigation Strategies to Reduce Opioid-Related Morbidity and Mortality in the US
    Ballreich, Jeromie
    Mansour, Omar
    Hu, Ellen
    Chingcuanco, Francine
    Pollack, Harold A.
    Dowdy, David W.
    Alexander, G. Caleb
    [J]. JAMA NETWORK OPEN, 2020, 3 (11)
  • [8] Release from prison - A high risk of death for former inmates
    Binswanger, Ingrid A.
    Stern, Marc F.
    Deyo, Richard A.
    Heagerty, Patrick J.
    Cheadle, Allen
    Elmore, Joann G.
    Koepsell, Thomas D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (02) : 157 - 165
  • [9] Mortality After Prison Release: Opioid Overdose and Other Causes of Death, Risk Factors, and Time Trends From 1999 to 2009
    Binswanger, Ingrid A.
    Blatchford, Patrick J.
    Mueller, Shane R.
    Stern, Marc F.
    [J]. ANNALS OF INTERNAL MEDICINE, 2013, 159 (09) : 592 - 600
  • [10] Male drugs-related deaths in the fortnight after release from prison: Scotland, 1996-99
    Bird, SM
    Hutchinson, SJ
    [J]. ADDICTION, 2003, 98 (02) : 185 - 190